Paternal valproate exposure and child neurodevelopment: What this Taiwan study found
This nationwide Taiwan study included 2,583,503 people born from 2001 through 2016 and followed through 2021.
This hub covers epilepsy comorbidities, which are the other conditions that often show up alongside seizures (like ADHD, anxiety, depression, autism, and sleep issues). Plain-language research takeaways for families.
Often both. Shared brain networks, stress, sleep disruption, and medication effects can all contribute.
Track timing: New symptoms after med changes or dose increases may point to side effects.
If school is hard, attention/memory changes, or thereโs concern about learning, yes, it can guide supports.
Sometimes. Improving sleep and stress can reduce seizure susceptibility in some people.
This nationwide Taiwan study included 2,583,503 people born from 2001 through 2016 and followed through 2021.
Researchers described co-occurring health conditions in 1,054 children and youth with validated epilepsy diagnoses in Norway.
Researchers analyzed two large, nationally representative U.S.
This study looked at adding ethosuximide, a seizure medicine, to treatment for children with developmental and epileptic encephalopathy with spike-wave activation in sleep (D/EE-SWAS).
This study followed 35 children and adolescents with epilepsy who started levetiracetam, a common seizure medicine.
This paper is a review, not a new experiment.
This study looked at whether fracture risk differed between two seizure medicines, lacosamide and levetiracetam, when each was used alone in adults with epilepsy.
This study followed 665 adults with drug-resistant focal epilepsy after an anti-seizure medicine was added or substituted.
Researchers looked at early real-world use of phenylbutyrate in children with 2 rare developmental and epileptic encephalopathies: STXBP1-encephalopathy and SLC6A1-encephalopathy.